We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Anastrozole tablets, USP 1mg (Accord, USA)
Section 19A approved medicine
(Approval lapsed) Anastrozole tablets, USP 1mg (Accord, USA)
Section 19A approval holder
Reach Pharmaceuticals Pty Ltd ABN 25 623 897 183
Phone
0422 429 648
Approved until
Status
Expired
Medicines in short supply/unavailable
APO-ANASTROZOLE anastrozole 1 mg film-coated tablet blister pack - ARTG 266676
ARIANNA 1 anastrozole 1 mg film-coated tablet blister pack - ARTG 259991
ARIANNA 1 anastrozole 1 mg film-coated tablet blister pack - ARTG 259991
Indication(s)
Early breast cancer:
Adjuvant treatment of early breast cancer in postmenopausal women with estrogen/progesterone-receptor-positive-disease.
Advanced breast cancer:
First line treatment of advanced breast cancer in postmenopausal women with estrogen/progesterone-receptor-positive disease.
Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy. Patients with estrogen-receptor-negative disease and patients who have not responded to previous tamoxifen therapy rarely respond to anastrozole.
Images
